US Copyright Office 17 priorities

Register of Copyrights Maria A. Pallante has made public the “priorities and special projects” of the US Copyright Office from October 2011 to October 2013. The ambitious work plan sets 17 priorities in the areas of copyright policy and administrative practices, and 10 special projects “to improve the quality and efficiency of the U.S. Copyright Office’s services.”

The 16 page document is available here
Comments should be sent to registerofcopyrights@copyright.gov

Here’s a quick outline:

3 Studies

Continue Reading

Uncategorized

WTO TRIPS Council: India raises concerns on ACTA and TPPA on discussion of “Trends in the Enforcement of IPRs”

On 25 October 2011, India delivered the following intervention at the WTO TRIPS Council raising concerns on ACTA and the TPPA during discussions of “Trends in the Enforcement of Intellectual Property Rights”. On ACTA, India voiced concerns on the scope of ACTA’s civil enforcement measures, border measures potential role in the seizure of generic medicines, third party liability, damages and also raised systemic issues such as how WTO MFN obligations would affect WTO members who are not ACTA parties,

Uncategorized

Recent cancer drug prices

2010

April 29, 2010.
Brand name: Provenge
Generic name: Sipuleucel-T
Marketed by: Dendreon
Indication: therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.
FDA press release here.
US Price: $31,000 per infusion. A full course of treatment is three infusions over a one-month period, or $93k.
Continue Reading

Uncategorized

USPTO issued patents mentioning ritonavir in a patent claim

This note begins by looking at patents issued by the USPTO that specifically mention the term ritonavir in the patent claims, or mention the NIH contract that was used to fund the early development of the product. This includes 194 patents that cite ritonavir in the patent claims, and another 42 patents that cite the NIH contact that funded the early ritonavir work. We also provide quotes from an August 19, 2011 WIPO report on the patent landscape for ritonavir that found 805 patent families related to ritonavir.

Continue Reading

Uncategorized

UNITAID 3rd Consultative Forum; Nineteen IP recommendations

On 4-5 October 2011, UNITAID held its third Consultative Forum giving stakeholders the opportunity to view UNITAID’s achievements to date as well as provide input on UNITAID’s activities moving forward. Attendees at the forum included civil society, NGOs, implementing partners, representatives from the pharmaceutical industry and private foundations, and governmental officials. Several of the presentations from the IP workshop as well as the recommendations from the IP workshop are attached below.

Continue Reading

Uncategorized

KEI comment on US signing of ACTA

Today USTR was pointing to four documents to explain the U.S. decision to sign the Anti-Counterfeiting Trade Agreement. While it was not surprising that the United States signed the agreement, KEI was disappointed that the statements did not address the issue of the inconsistencies between US law and the ACTA, or make any commitments that the ACTA Committee would operate in an open, transparent and inclusive manner.

These are the USTR documents:

Uncategorized

David Hammerstein tweets on the European Parliament hearing on the WIPO Treaty for Blind negotiations

These were copied from David Hammerstein’s twitter feed, October 3, 2010.

http://twitter.com/#!/dahammerstein

  • Treaty Visually Impaired before European Parliament at aprox. 15:30. Webstream: bit.ly/kQgrDf info: bit.ly/oDLbL0
  • This is the correct link for the webstreaming of Treaty of visually impaired before the European Parliament: bit.ly/PwS9T
  • Session begins in EP´s Petition Committee on Treaty for Visually Impaired. Chris Friend, World Blind Union condemns us to “book famine”
  • Continue Reading

Uncategorized

ACTA is not consistent with US laws on injunctions and damages

Two areas where ACTA is inconsistent with US law, injunctions and damages
KEI Policy Brief, 2011:2
30 September 2011, revised 3 October 2011
James Love and Krista Cox


As the U.S. is reportedly about to sign ACTA, we wanted to point out two important areas where ACTA is not consistent with U.S. law. These are the sections of ACTA dealing with injunctions and damages. Below we have included the text from ACTA and the WTO TRIPS agreement on these two topics.

Continue Reading

Uncategorized